Kenneth B. Mccredie
#133,281
Most Influential Person Now
Kenneth B. Mccredie's AcademicInfluence.com Rankings
Kenneth B. Mccrediephilosophy Degrees
Philosophy
#6603
World Rank
#9664
Historical Rank
Logic
#3744
World Rank
#4944
Historical Rank
Kenneth B. Mccrediebiology Degrees
Biology
#8940
World Rank
#12086
Historical Rank
Molecular Biology
#1171
World Rank
#1197
Historical Rank
Download Badge
Philosophy Biology
Why Is Kenneth B. Mccredie Influential?
(Suggest an Edit or Addition)Kenneth B. Mccredie's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. (1986) (692)
- Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. (1987) (599)
- Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia (1979) (529)
- Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. (1979) (497)
- Clinical investigation of human alpha interferon in chronic myelogenous leukemia. (1987) (350)
- Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. (1983) (315)
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemia (1989) (294)
- Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. (1987) (293)
- Characteristics of accelerated disease in chronic myelogenous leukemia (1988) (285)
- Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. (1986) (268)
- HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. (1988) (258)
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. (1991) (253)
- Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. (1971) (244)
- Cells Capable of Colony Formation in the Peripheral Blood of Man (1971) (242)
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. (1989) (230)
- Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. (1988) (228)
- Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. (1985) (221)
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. (1990) (212)
- Acute promyelocytic leukemia. M.D. Anderson Hospital experience. (1986) (209)
- Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. (1979) (205)
- Causes of initial remission induction failure in acute myelogenous leukemia. (1982) (199)
- Response to salvage therapy and survival after relapse in acute myelogenous leukemia. (1989) (179)
- Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). (1992) (175)
- Factors related to length of complete remission in adult acute leukemia (1980) (169)
- The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation. (1980) (167)
- Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. (1987) (159)
- Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. (1974) (151)
- Improved prospects for long-term survival in adults with acute myelogenous leukemia. (1982) (144)
- Necrotizing colitis in patients with cancer. (1979) (142)
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA (1979) (137)
- A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). (1985) (136)
- Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. (1986) (133)
- RANDOMIZED TRIAL OF PROTECTED ENVIRONMENT — PROPHYLACTIC ANTIBIOTICS IN 145 ADULTS WITH ACUTE LEUKEMIA (1978) (125)
- A four‐year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia (1981) (119)
- High‐dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors (1980) (119)
- Long‐term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseases (1979) (118)
- Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. (1973) (114)
- Restoring patency of occluded central venous catheters. (1980) (111)
- A prognostic factor analysis for use in development of predictive models for response in adult acute leukemia (1982) (110)
- A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. (1983) (109)
- Prognostic factors in acute leukemia. (1976) (109)
- Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults. (1982) (104)
- Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. (1985) (103)
- A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models. (1976) (102)
- Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia. (1987) (100)
- Chemotherapy of malignant lymphoma with adriamycin. (1973) (98)
- Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study. (1973) (94)
- Subacute pulmonary failure complicating therapy with high‐dose ara‐C in acute leukemia (1985) (93)
- Malignant gingival and skin "infiltrates" in adult leukemia. (1983) (93)
- 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. (1980) (92)
- Increased Granulocyte Collection with the Blood Cell Separator and the Addition of Etiocholanolone and Hydroxyethyl Starch (1974) (90)
- Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. (1989) (90)
- Therapy of acute myelogenous leukemia (1978) (88)
- Fatal pulmonary failure complicating high‐dose cytosine arabinoside therapy in acute leukemia (1990) (86)
- Oral infections associated with chemotherapy in adults with acute leukemia. (1982) (86)
- The characteristics and outcome of patients with late relapse acute myelogenous leukemia. (1988) (85)
- High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis. (1986) (84)
- The relevance of reticulin stain‐measured fibrosis at diagnosis in chronic myelogenous leukemia (1987) (84)
- Oncogene expression in human leukemia. (1984) (83)
- Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia. (1974) (79)
- Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count (1983) (78)
- Chronic myelogenous leukaemia: haematological remissions with alpha interferon (1986) (76)
- Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor. (1990) (75)
- Effects of low doses of recombinant human granulocyte‐macrophage colony stimulating factor (GM‐CSF) in patients with myelodysplastic syndromes (1991) (75)
- Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy. (1976) (74)
- In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase. (1986) (74)
- Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. (1988) (71)
- The association of specific “favorable” cytogenetic abnormalities with secondary leukemia (1986) (70)
- Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP) (1981) (69)
- 5‐azacytidine in acute leukemia (1978) (68)
- Role of maintenance chemotherapy in acute promyelocytic leukemia (1987) (67)
- Quantitative analysis of the oral complications of antileukemia chemotherapy. (1986) (67)
- Phase II trial of mitoxantrone in refractory acute leukemia. (1983) (65)
- Leukocyte transfusion therapy for patients with host-defense failure. (1973) (64)
- Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus. (1975) (63)
- The importance of cytogenetic studies in adult acute lymphocytic leukemia. (1990) (62)
- Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients (1987) (61)
- Clinical and prognostic features of philadelphia chromosome‐negative chronic myelogenous leukemia (1986) (61)
- Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients. (1988) (61)
- Chemotherapy-induced oral mucositis in adult leukemia. (1981) (61)
- Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel (1979) (60)
- Human leukocyte interferon preparation blocks granulopoietic differentiation (1979) (60)
- Treatment of acute leukemia with 5-azacytidine (NSC-102816). (1973) (60)
- Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. (1992) (59)
- Autologous bone marrow transplantation in relapsed adult acute leukemia. (1980) (59)
- Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults. (1972) (58)
- AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH ADULT ACUTE LEUKEMIA IN RELAPSE (1978) (57)
- Loss of the Y chromosome in acute myelogenous leukemia: a report of 13 patients. (1985) (57)
- Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. (1984) (56)
- Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone. (1977) (54)
- Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemia. (1990) (54)
- Mitoxantrone and high‐dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia (1990) (54)
- Blastic crisis in chronic granulocytic leukemia: Experience in 39 patients (1974) (54)
- Biological effects of repeated leukapheresis of patients with chronic myelogenous leukemia. (1973) (54)
- Nutritional deficiencies in patients receiving cancer chemotherapy. (1990) (53)
- Ph-positive chronic myeloid leukemia with near-haploid conversion in vivo and establishment of a continuously growing cell line with similar cytogenetic pattern. (1987) (53)
- Phase II study of low‐dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia (1989) (53)
- Intensive chemotherapy induction followed by interferon‐alpha maintenance in patients with Philadelphia chromosome‐positive chronic myelogenous leukemia (1991) (53)
- Pretreatment flow cytometry of DNA content in adult acute leukemia. (1980) (52)
- The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support. (1981) (51)
- The effectiveness of rubidazone in hairy cell leukemia (leukemic reticuloendotheliosis). (1979) (51)
- Mitoxantrone and high‐dose cytosine arabinoside in refractory acute myelogenous leukemia (1988) (51)
- Oral complications of bone marrow transplantation in adults with acute leukemia. (1979) (51)
- Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment. (1978) (50)
- Coagulation Abnormalities Induced by β-Lactam Antibiotics in Cancer Patients (1983) (49)
- Reduction of ifosfamide toxicity using dose fractionation. (1976) (49)
- Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia (1988) (48)
- Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. (1984) (48)
- Infection prophylaxis in acute leukemia (1984) (48)
- Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence, and prognosis. (1972) (47)
- Predicting relapse of human leukemia by means of premature chromosome condensation. (1980) (47)
- Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high‐dose cytosine arabinoside (1988) (45)
- Intensive treatment of acute leukemia in adults 70 years of age and older (1987) (43)
- Orofacial aspergillosis in acute leukemia. (1985) (43)
- The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia. (1987) (43)
- Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. (1987) (41)
- Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. (1988) (41)
- A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia. (1985) (39)
- Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia. (1986) (39)
- Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. (1988) (38)
- Reverse transcriptase in leukocytes of leukemic patients in remission. (1976) (38)
- A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. (1987) (38)
- Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP). (1981) (37)
- Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel. (2000) (36)
- Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21. (1989) (36)
- Heterogeneity in acute undifferentiated leukemia. (1988) (35)
- Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia. (1990) (34)
- Evaluation of silicone elastomer catheters for long-term intravenous chemotherapy. (1985) (34)
- High dose cyclophosphamide, BCNU, and VP‐16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia (1987) (34)
- T lymphocyte and monocyte-macrophage interaction in colony-stimulating activity elaboration in man. (1979) (34)
- A phase 1 and 2 trial of rubidazone in patients with acute leukemia. (1977) (33)
- Acute unclassified leukemia. A clinicopathologic study with diagnostic implications of electron microscopy (1980) (33)
- Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons (1988) (33)
- Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high‐dose decadron (1987) (33)
- Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin. (1978) (32)
- Developmental therapy in adult acute leukemia. (1976) (32)
- Chemoimmunotherapy of adult acute leukemia (1981) (32)
- Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy. (1979) (30)
- Diurnal changes in circulating myeloid progenitor cells in man (1980) (30)
- Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. (1993) (30)
- Chemotherapy-associated oral hemorrhages in adults with acute leukemia. (1984) (29)
- DNA aneuploidy in adult acute leukemia. (1987) (29)
- Fludarabine therapy in chronic lymphocytic leukemia (CLL). (1988) (29)
- Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid. (1979) (29)
- Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia (1989) (28)
- Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts. (1974) (26)
- Systemic aspergillosis as cause of myocardial infarction (1986) (26)
- Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy (1981) (26)
- Philadelphia chromosome-positive adult acute leukemia with monosomy of chromosome number seven: a subgroup with poor response to therapy. (1983) (26)
- Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines (1987) (25)
- Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients (1984) (25)
- Premature chromosome condensation studies in human leukemia. I. Pretreatment characteristics. (1979) (25)
- Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. (1981) (24)
- Platelet and leukocyte transfusions in acute leukemia. (1974) (24)
- Long-Term I.V. Therapy: A New Approach (1979) (24)
- Some studies on natural killer cells in man. (1979) (24)
- Cutaneous complications of cancer chemotherapy. (1975) (23)
- Mitoxantrone and high‐dose etoposide for patients with relapsed or refractory acute leukemia (1991) (23)
- Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy (1985) (23)
- Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions. (1976) (23)
- Standardization of platelet function tests (1981) (23)
- Immunodiagnosis of acute leukemia: detection of residual disease. (1974) (23)
- Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatment. (1973) (22)
- Repeated high-dose cyclophosphamide, BCNU and VP-16-213 and autologous bone marrow transplantation in adult acute lymphocytic leukemia in first remission. (1984) (22)
- In vivo cellular kinetic and pharmacological studies1–β–d– arabinofuranosylcytosine and 3–deazauridine chemotherapy for relapsing acute leukemia (1981) (22)
- Treatment of acute leukemia in protected environment units (1979) (21)
- Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia. (1988) (21)
- Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon. (1987) (21)
- Successful control of systemic aspergillus niger infections in two patients with acute leukemia (1975) (21)
- Comparison of transparent dressing to paper tape dressing over central venous catheter sites. (1986) (20)
- Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia. (1987) (20)
- Unusual mucocutaneous infections in immunosuppressed patients with leukemia--expansion of an earlier study. (1986) (19)
- Natural Killer Cells in Man: Their Possible Involvement in Leukemia and Bone Marrow Transplantation (1979) (19)
- Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia. (1988) (19)
- Oxymetholone in Refractory Anaemia (1969) (19)
- Human leukocyte interferon‐mediated granulopoietic differentiation arrest and its abrogation by lithium carbonate (1982) (19)
- Successful control of systemic aspergillus niger infections in two patients with acute leukemia (1975) (19)
- Remission from central nervous system involvement in adults with acute leukemia effect of intensive therapy and prognostic factors (1985) (19)
- Primary and Secondary Immune Responses in the Evaluation of Immunocompetence and Prognosis in Cancer Patients (1974) (18)
- Old Age: A Sign of Poor Prognosis in Patients With Chronic Myelogenous Leukemia (1987) (18)
- Combination 6‐mercaptopurine‐adriamycin in refractory adult acute leukemia (1975) (18)
- Generation of cytotoxic NK cells in peripheral blood and bone marrow of patients with acute myelogenous leukemia after continuous infusion with recombinant interleukin‐2 (1991) (18)
- Induction of differentiation in human myeloid leukemia cells with cytosine arabinoside. (1986) (18)
- Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis. (1973) (17)
- Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications. (1985) (17)
- Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital. (1985) (17)
- Adult acute leukemia studies utilizing cytarabine: early Southwest Oncology Group trials. (1982) (17)
- Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells. (1980) (17)
- Management of adult acute leukemia a southwest oncology group study (1983) (16)
- Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion system (1977) (16)
- Autologous bone marrow transplantation in relapsed adult acute leukemia and solid tumors. (1979) (16)
- Autologous bone-marrow transplantation in relapsed adult acute leukaemia. (1979) (15)
- Premature chromosome condensation studies in human leukemia: 5. Prediction of early relapse. (1984) (15)
- Autologous bone marrow transplantation in a case of acute adult leukemia. (1977) (15)
- Comparison of results of salvage therapy in adult acute myelogenous leukemia. (1987) (15)
- Prediction of complete remission in patients with refractory acute leukemia treated with AMSA. (1984) (15)
- Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia. (1981) (15)
- Disseminated bcg disease associated with immunotherapy by scarification in acute leukemia (1978) (15)
- Early consolidation chemotherapy for adults with acute leukemia in remission. (1976) (15)
- Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study. (1981) (14)
- Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia. (1991) (14)
- Unusual mucocutaneous infections in immunosuppressed patients with leukemia. (1979) (14)
- Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2. (1987) (14)
- Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture. (1997) (13)
- Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia. (1986) (13)
- Rescue by peripheral blood mononuclear cells in dogs from bone marrow failure after total‐body irradiation (1984) (13)
- High‐Dose Cyclophosphamide, BCNU, and Etoposide Followed by Autologous Bone Marrow Rescue as Treatment for Adult Acute Leukemia in Relapse (1986) (13)
- Platelet replacement therapy: a clinical assessment. (1978) (12)
- Establishment, characterization and differentiation induction of a new human diploid myelomonocytic cell line (HL-92) derived from a patient with acute myelomonocytic leukemia. (1982) (12)
- Phase II trial of dihydroxyanthracenedione in acute leukemia (1982) (12)
- Natural killer cells in mice and man and their possible biological significance (1978) (12)
- Autologous bone marrow transplantation in relapsed adult acute leukemia. (1979) (11)
- Coagulation abnormalities induced by beta-lactam antibiotics in cancer patients. (1983) (11)
- Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia. (1979) (11)
- Premature chromosome condensation studies in human leukemia. 2. Proliferative potential changes after induction therapy for AML patients. (1980) (11)
- Effect of antileukemia chemotherapy on marrow, blood, and oral granulocyte counts. (1991) (11)
- Use of a 4'-(9 acridinylamino) methanesulfon-m-anisidine (AMSA), cytosine-arabinoside (ara-C) vincristine prednisone combination (AMSA-OAP) in poor risk patients in acute leukemia (1981) (11)
- Clinical studies with rubidazone. (1979) (10)
- Urinary amino acid excretion in acute leukemia (1976) (10)
- In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia. (1981) (10)
- Mucocutaneous granulocytic sarcomas of the head and neck. (1987) (10)
- Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia (1978) (10)
- Intermittent guanazole therapy in adult acute leukemia (1973) (10)
- Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines. (1987) (10)
- Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemia. (1987) (10)
- Preferential expression of double-stranded ribonucleic acid in tumor versus normal cells: biological and clinical implications. (1985) (10)
- Prospective randomized trial of antibiotic prophylaxis in acute leukemia. (1985) (9)
- Combinations of arabinosyl cytosine and 6-thioguanine for treatment of adults with acute leukemia. (1975) (9)
- Frequency of HLA antigens in chronic myelocytic leukemia. (1977) (9)
- Microbial mucocutaneous infections in acute adult leukemia. Results of an 18-year inpatient study. (1986) (9)
- Phase I--II study of 3-deazauridine in adults with acute leukemia. (1981) (9)
- Significance of PHA induced clonogenic cells in chronic myeloid leukemia and early acute myeloid leukemia. (1976) (9)
- Evidence for the Separate Human T-Lymphocyte Subpopulations That Collaborate With Autologous Monocyte/Macrophages in the Elaboration of Colony-Stimulating Activity and Those That Suppress This Collaboration (1983) (8)
- Prognostic factors for survival of 194 patients with low infiltrate leukemia. (1986) (8)
- 5-AZACYTIDINE AND ARABINOSYL ADENINE FOR THE TREATMENT OF ACUTE LEUKEMIA* (1977) (8)
- Successful human cadaveric renal homograft with major blood-group incompatibility. (1967) (8)
- Current Status of Therapy for Acute Leukemia (1971) (8)
- Platelet and granulocyte transfusion therapy. (1977) (8)
- T-cell receptor gamma chain gene rearrangement in acute myelogenous leukemia--evidence for lymphoid lineage prematurity. (1987) (7)
- Neocarzinostatin: A phase I clinical trial with five‐day intermittent and continuous infusions (1979) (7)
- Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells. (1988) (7)
- Identification of T lymphocyte subpopulations that regulate elaboration of granulocyte‐macrophage colony stimulating factor (1984) (6)
- Determination of clonality in acute nonlymphocytic leukemia by restriction fragment length polymorphism and methylation analysis. (1987) (6)
- Blood components in the care of the cancer patient (1978) (6)
- A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia. (1976) (6)
- Mucocutaneous herpetic infections during cancer chemotherapy. (1988) (6)
- Human malignancy-associated nucleolar antigen as a marker for tumor cells in patients with acute leukemia (1984) (6)
- The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging. (1988) (6)
- Clinical Evalutions of Toxic Effects of cis-Platinum (II) Diamminedichloride (1974) (6)
- Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons. (1988) (6)
- Premature Chromosome Condensation Studies in Human Leukemia (2005) (5)
- Analysis of nuclear m-AMSA content by DNA fluorochrome competition. (1986) (5)
- Principles of Continuous Flow Cell Separation in a Circumferential Flow Disposable Channel (1980) (5)
- External expressions of internal malignancy. (1987) (5)
- Rearrangement and enhanced expression of c-myc oncogene in fresh tumor cells obtained from a patient with acute lymphoblastic leukemia. (1986) (5)
- Evidence for the separate human T-lymphocyte subpopulations that collaborate with autologous monocyte/macrophages in the elaboration of colony-stimulating activity and those that suppress this collaboration. (1983) (5)
- Amsacrine: a new drug for hematological malignancies. (1985) (5)
- Prognostic factors in hairy cell leukemia. (Leukemic reticuloendotheliosis) (1984) (5)
- Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia. (1989) (5)
- Remission induction therapy with a rubidazone containing combination (ROAP) in acute leukemia (1977) (5)
- Acute leukemia in adults, 1977 (1977) (4)
- Association of circulating immune complexes with cytogenetic abnormalities but not with prognosis in acute nonlymphocytic leukemia. (1984) (4)
- A controlled clinical trial to evaluate a protected environment and prophylactic antibiotic program in the treatment of adult acute leukemia. (1975) (4)
- Biologic and Treatment Determinants of Curability in Acute Myelogenous Leukemia (1986) (4)
- Clinical and pharmacologic studies with rubidazone (R) in adults with acute leukemia (AL) (1976) (4)
- Comparison of results of salvage therapy in acute leukemia (1982) (4)
- Neutropenia and infection following cancer chemotherapy. (1976) (4)
- Necrotizing dermatitis in patients receiving cancer chemotherapy. (1987) (4)
- Chemoimmunotherapy of adult acute leukemia (CIAL) (1977) (4)
- The Use of Autologous Bone Marrow Transplantation after High-Dose Cytoreductive Therapy in Various Types of Malignancies in Man (1979) (4)
- Effect of Recombinant Tumor Necrosis Factor a in vitro and Its Modulation by a and y Interferons (2005) (3)
- Human malignancy-associated nucleolar antigen as a marker for tumor cells in patients with acute leukemia. (1984) (3)
- Clinical studies of beta-thioguanine deoxyriboside alone and in combination with arabinosyl cytosine. (1976) (3)
- Short-term sequential (S-TS) chemotherapy in young patients with acute myelogenous leukemia (AML) (1981) (3)
- Histocompatibility antigens in adult acute leukemia. (1977) (3)
- LYMPHOMA-ASSOCIATED AND HL-A ANTIGENS IN THE MIXED LEUKOCYTE REACTIVITY BETWEEN IDENTICAL SIBLINGS (1973) (3)
- Arabinosyl adenine (ARA-A) as an antitumor agent (1974) (3)
- Management of Bacterial Infections in Cancer Patients (1976) (3)
- Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia. (1990) (3)
- Treatment of acute myelogenous leukemia with chemotherapy and hematopoietic growth factors (1990) (2)
- Current concepts in acute leukemia. (1977) (2)
- Acute myelomonocytic leukemia associated with abnormalities of chromosome 16: a light and electron microscopic study. (1987) (2)
- Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSF. (1990) (2)
- New progressive factors affecting response and survival in adult acute leukemia. (1974) (2)
- Treatment of adult acute myeloblastic leukemia. (1979) (2)
- Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitro. (1988) (2)
- Continuous-infusion amsacrine in patients with refractory acute myelogenous leukemia. (1987) (2)
- High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia. (1982) (2)
- Karyotype of leukemia cells consistently predicts for response to therapy and survival following salvage therapy in acute myeloblastic leukemia. (1990) (2)
- Leukemia-associated skin infiltrates. (1989) (2)
- 2-Chlorodeoxyadenosine: A new anticancer agent in lymphoid malignancies (1991) (2)
- Cross cellular contamination in plateletpheresis, leukapheresis and plasma exchange. (1981) (2)
- Superficial head and neck metastases in adults with widespread cancer. (1980) (2)
- Suitability of a new stable acetal analogue of aldoifosphamide for purging leukemic cells from human bone marrow. (1990) (1)
- Treatment of refractory adult acute leukemia with sequential L-asparaginase (L-ASP) and high dose methotrexate (MTX) (1978) (1)
- Relapse of adult acute myelogenous leukemia isolated in testicle. (1989) (1)
- Clinical resistance and sensitivity to chemotherapy in human acute leukemia: In vitro correlation with drug uptake and lack of potentiation by verapamil (1985) (1)
- Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel. 1979. (2000) (1)
- Biologic agents for the management of hematological disorders: chronic myeloid leukemia. (1987) (1)
- Vascular access by means of surgically created arteriovenous fistulas in the chemotherapy of acute leukemia: a preliminary report. (1974) (1)
- Autologous bone marrow transplantation in acute leukemia. (1979) (1)
- In vitro colony growth of acute myelogenous leukemia. (1976) (1)
- Induction of suppressor cells with corynebacterium parvum. Abstr. (1978) (1)
- Protected environments (PE) and prophylactic antibiotics in remission induction therapy of adults with acute leukemia (1974) (1)
- Indications for HLA typing in granulocyte and platelet concentrate transfusions. (1981) (0)
- Sensitivity to phenindione. (1963) (0)
- Granulocyte collection and transfusion. (1977) (0)
- Proceedings: Management of acute leukemia. (1972) (0)
- Interferon: an early evaluation. (1981) (0)
- Continuous IV arabinosylcytosine (Ara C) delivered by a new portable infusion system (1977) (0)
- New approaches to the treatment of chronic myelogenous leukemia. (1985) (0)
- Therapy of acute myelogeneous leukemia. (1978) (0)
- Allergic Pericarditis (1964) (0)
- Acute leukaemia in adults: 1977 (1977) (0)
- Splenectomy in chronic myelogenous leukemia (CML) patients: A long term follow up (1979) (0)
- Intertriginous infections in adults receiving antileukemia chemotherapy. (1989) (0)
- Prognostic determinants in patients (PTS) with Philadelphia chromosome-negative (Ph-Ve) benign phase chronic myelogenous leukemia (CML) (1985) (0)
- Granulocyte transfusions. (1977) (0)
- Prognostic factors in response to anthracyclines. (1981) (0)
- White blood cell transfusions in the management of infections in neutropenic patients. (1976) (0)
- Treatment ofGoodpasture syndrome withcyclophosphamide, prednisone andplasma exchange transfusions (2002) (0)
- Patterns of Failure in Salvage Therapy for Acute Myelogenous Leukemia (1992) (0)
- Brown sequard syndrome secondary to soft tissue infection in a patient with acute lymphocyte leukemia (2004) (0)
- To-day's Drugs: Sulphonamides (2) (1964) (0)
- Blood component collection and transfusion. (1979) (0)
- Selective transfusion of blood components. (1981) (0)
- Circulating candida antigen in patients with malignant disease (1977) (0)
- Clinical use of Platelet Transfusion in Acute Leukaemia (1980) (0)
- Liquid culture assays of mouse bone marrow granulopoiesis. (1974) (0)
- Interferon: an early evaluation. (1980) (0)
- Use of Granulocyte-Macrophage Colony-Stimulating Factor Prior to Chemotherapy of Newly Diagnosed AML (1992) (0)
- in thronic Long-Term Results of CAP Therapy Lymphocytic Leukemia (1990) (0)
- Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients. (1977) (0)
- Oncologic origins of overt scalp metastases (1991) (0)
- Evaluation of Silicone Elastomer Catheters for Long-Term Intravenous Chemotherapy (1985) (0)
- Interferon: an early evaluation. (1980) (0)
- Late intensification (LI) chemoimmunotherapy in adult acute leukemia (AL) (1979) (0)
This paper list is powered by the following services:
